NASDAQ: MDGL - Madrigal Pharmaceuticals, Inc.

Yield per half year: +17.2%
Dividend yield: 0.00%
Sector: Healthcare

Current price
303.64 $
Average price
398.05 $ +31.09%

Price based on EPS
336.93 $ +10.97%
Discount price Net Income
459.17 $ +51.22%
10/10

Price based on EPS

Price = Price * (100 - CAGR EPS * Excess Key Rate) / 100
Key Rate = Key rate
Fair price = 336.93 $
Current price = 303.64 $ (difference = +10.97%)


Data

Discounted Cash Flow (Based EBITDA)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = ∑ (Future Ebitda / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -471.17 $
Current price = 303.64 $ (difference = -255.17%)


Data

Discounted Cash Flow (Based FCF)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield) ^ 5
Company Value = ∑ (FCF / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -476.09 $
Current price = 303.64 $ (difference = -256.79%)


Data

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription